Purev Batchuluun

Suggest Changes
  • Citations Per Year
Learn More
BACKGROUND An increasing number of studies is now devoted to immunotherapy of cancer. We evaluated the clinical benefit of hepcortespenlisimut-L (Hepko-V5 [formerly known as V5])-an oral therapeutic(More)
  • 1